Wang, S., Hu, X., & Pan, Y. (2019). Low-density lipoprotein cholesterol levels are positively associated with the risk of endobronchial biopsy-induced refractory hemorrhage in patients with lung cancer. Lipids in Health & Disease, 18(1), N.PAG. https://doi.org/10.1186/s12944-019-1140-2
Chicago Style (17th ed.) CitationWang, Saibin, Xianqing Hu, and Yibin Pan. "Low-density Lipoprotein Cholesterol Levels Are Positively Associated with the Risk of Endobronchial Biopsy-induced Refractory Hemorrhage in Patients with Lung Cancer." Lipids in Health & Disease 18, no. 1 (2019): N.PAG. https://doi.org/10.1186/s12944-019-1140-2.
MLA (9th ed.) CitationWang, Saibin, et al. "Low-density Lipoprotein Cholesterol Levels Are Positively Associated with the Risk of Endobronchial Biopsy-induced Refractory Hemorrhage in Patients with Lung Cancer." Lipids in Health & Disease, vol. 18, no. 1, 2019, p. N.PAG, https://doi.org/10.1186/s12944-019-1140-2.